Press release
Parkinson's Disease Treatment Market to Grow Rapidly in Near Future | Global key players- GlaxoSmithKline Plc, Merck KGaA, Novartis AG, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Bausch Health
The Parkinson's disease treatment market is anticipated to grow in the forecast, owing to the factors such as increasing geriatric population, government funding for Parkinson's disease treatment research and new product launches. In addition, initiatives undertaken by various government and non-government organizations as well as a promising pipeline of the disease medications is expected to offer significant growth opportunities in the market during the forecast period.
The "Global Parkinson's Disease Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. It provides key statistics on the market status of the leading Parkinson's disease treatment market players and offers key trends and opportunities in the market.
Get free sample copy of report @
https://www.premiummarketinsights.com/sample/TIP00010454
Some of the key players operating in the market are GlaxoSmithKline Plc, Merck KGaA, Novartis AG, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Bausch Health, H. Lundbeck A/S, Sun Pharmaceutical Industries Ltd, AbbVie Inc., Impax Laboratories, LLC
The global Parkinson's disease treatment market is segmented on the basis of drug class, distribution channel and geography. Based on type, the market is segmented as carbidopa/levodopa, dopamine receptor agonists, Mao inhibitors, comt inhibitors, anticholinergic and other drugs. On the basis of distribution channel, the global Parkinson's disease treatment market is segmented into, hospital pharmacies, retail pharmacies, and online pharmacies.
It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Parkinson's disease treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Purchase this report@:
https://www.premiummarketinsights.com/buy/TIP00010454
Table of Contents
1. Introduction
2. Key Takeaways
3. Parkinson’s Disease Treatment Market Landscape
4. Market - Key Industry Dynamics
5. Parkinson’s Disease Treatment Market Analysis- Global Analysis
6. Parkinson’s Disease Treatment Market Revenue And Forecasts To 2027 – Drug Class
7. Market Revenue And Forecasts To 2027 – Distribution Channel
8. Market Revenue And Forecasts To 2027 – Geographical Analysis
9. Industry Landscape
10. Competitive Landscape
11. Parkinson’s Disease Treatment Market, Key Company Profiles
12. Appendix
About us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
We provide best in classcustomer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.
Contact us:
Premium Market Insights,
Contact Person: Sameer Joshi
Email: sales@premiummarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Treatment Market to Grow Rapidly in Near Future | Global key players- GlaxoSmithKline Plc, Merck KGaA, Novartis AG, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Bausch Health here
News-ID: 1714311 • Views: …
More Releases from Premium Market Insights
The Future of HVAC: Trends and Innovations
The Europe HVAC System Market HVAC system market was valued at US$ 50,772.07 million in 2022 and is expected to reach US$ 1,25,024.86 million by 2030; it is estimated to grow at a CAGR of 11.9% from 2022 to 2030.
𝐆𝐫𝐚𝐛 𝐏𝐃𝐅 𝐓𝐨 𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞➜ https://www.businessmarketinsights.com/sample/BMIRE00026922?utm_source=OpenPR&utm_medium=10694
Rise in Demand for Energy-Efficient Solutions Fuel the Europe HVAC System Market
Greenhouse gases are the primary sources of global warming and climate change. These gases absorb…
Automated External Defibrillators Market New Business Opportunities and Investme …
The Automated External Defibrillators Market is estimated to reach US$ 2,207.94 million in 2030 from US$ 1,556.21 million by 2030; the market is projected to record a CAGR of 4.5% from 2022 to 2030.
Some of the key driving factors for the automated external defibrillators market growth are the increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators. However, performance issues related to automated external…
Hydrolyzed Collagen Market Types and Applications, Industry Drivers, Future Dema …
The Hydrolyzed Collagen Market was valued at US$ 946.43 million in 2022 and is projected to reach US$ 1,322.60 million by 2028; it is expected to register a CAGR of 5.7% from 2022 to 2028.
Various end-use industries are adopting business expansion strategies and scaling production capacity to provide better customer satisfaction. For instance, in July 2020, Rousselot and Giusto Faravelli announced a distribution partnership in Italy, effective from October 2020.…
Aroma Ingredients Market Expectations & Growth, Trends Highlighted Until 2028
The Aroma Ingredients Market was valued at US$ 5376.90 million in 2021 and is projected to reach US$ 7692.62 million by 2028; it is expected to grow at a CAGR of 5.2% from 2021 to 2028.
Aroma ingredients are basically isolates of naturally sourced ingredients or chemically produced and are used as ingredients to add aromas or fragrance to various cosmetic and personal care products.
Based on product type, the global aroma…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
